Alexandria Venture Investments and Biomed Realty Ventures were among the investors as the immunotherapy developer closed the round's final tranche.

SMK Diagnostics is developing a sensor that can detect mosquito-borne diseases more quickly and cheaply than alternative methods.

Higi, which received funding from BlueCross BlueShield Venture Partners last year, has raised a further $21.3m.

The blood pump developer raised $16.3m from public investment bank BPIfrance, following a Novo Seeds-backed round two years ago.

The healthcare data analytics software provider has now raised more than $31m in total, after BlueCross BlueShield Venture Partners and Intel Capital reinvested.

Clinical data analysis platform Shyft has agreed to a $195m purchase by investor Medidata that will also allow McKesson and UnitedHealth to exit.

Merck & Co is one of the investors set to exit antibody drug developer Visterra after Otsuka Pharmaceutical agreed to buy the company for $430m.

Inra spinout Nextbiotix has attracted capital from the institute itself as well as Biocodex and other institutional investors.